A team of researchers from Samoa, New Zealand and the U.S. has found that the leaves of the Samoan tree, matalafi, are as good at relieving inflammation as ibuprofen. In their paper published in Proceedings of the National ...
The story line sounds familiar: a popular pain drug becomes a new way to get high as prescribing by doctors soars.
May 4, 2018
2
2087
At only pennies per dose, metformin is a Type 2 diabetes drug with distant roots in Medieval folk medicine and a powerful capacity to reduce body weight, fat mass, circulating glucose—and prevent the disorder altogether ...
(HealthDay)—Scientists have created a compact machine that can churn out thousands of doses of prescription medication in a day—putting the capabilities of a drug-manufacturing plant into a device the size of a kitchen ...
Apr 1, 2016
0
609
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 percent, reveals a study in the laboratory by an international collaboration ...
Aug 6, 2021
4
2098
Even though clinical trials haven't shown it works against COVID-19, doctors continue to prescribe ivermectin—and a new study suggests health insurers are heavily subsidizing the cost of those prescriptions.
Jan 13, 2022
0
267
Though cannabis is often associated with "the munchies" in popular culture, University of Toronto researcher Justin Matheson is asking whether cannabinoids—naturally occurring compounds in the plant—can actually be used ...
Jan 5, 2022
0
57
(HealthDay)—Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.
Sep 5, 2018
0
851
A Te Herenga Waka–Victoria University of Wellington Ph.D. graduate who was based at the Gillies McIndoe Research Institute (GMRI) has found a potential new source of help for colon cancer patients—medications used to ...
Feb 18, 2022
0
29
Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".
May 4, 2012
0
0
